<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-2-27.anc" start="11928" end="11939" sStart="-1" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="Aliquots (20 ?l) of the cell lysates were &lt;b&gt;transferred&lt;/b&gt; into wells of 96-well microplates and ?-galactosidase was quantitated using the Galacto-Light Plus System chemiluminescence reporter assay in a Microlight ML 2250 luminometer (Dynatech Laboratories, Inc." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-2-27.anc" start="11928" end="11939" sStart="null" offset="0" sid="null" wn="3 2" wnkey="null" text="Aliquots (20 ?l) of the cell lysates were &lt;b&gt;transferred&lt;/b&gt; into wells of 96-well microplates and ?-galactosidase was quantitated using the Galacto-Light Plus System chemiluminescence reporter assay in a Microlight ML 2250 luminometer (Dynatech Laboratories, Inc." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-2-27.anc" start="11928" end="11939" sStart="null" offset="0" sid="null" wn="2" wnkey="transfer%2:40:01::" text="Aliquots (20 ?l) of the cell lysates were &lt;b&gt;transferred&lt;/b&gt; into wells of 96-well microplates and ?-galactosidase was quantitated using the Galacto-Light Plus System chemiluminescence reporter assay in a Microlight ML 2250 luminometer (Dynatech Laboratories, Inc." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-27.anc" start="30763" end="30769" sStart="null" offset="111" sid="r11.strong.j.0646" wn="1" wnkey="strong%3:00:00::" text="This might be due to the polysaccharide backbone of cellulose [ 60 ] with a propensity to form strong intermolecular hydrogen bonds and to be involved in hydrophobic interactions more than soluble dextrans [ 61 ] and galactose + 3,6-anhydrogalactose copolymers (= the saccharide moiety of carrageenan) [ 62 63 ] . Among the two polymers containing aryl sulfonates, poly(napthalene sulfonate) was more effective than poly(styrene-4-sulfonate) with respect to induction of gp41 six-helix bundles in HIV-1 BaL." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2334-2-27.anc" start="8817" end="8821" sStart="null" offset="0" sid="null" wn="1" wnkey="read%2:31:00::" text="Bound HRP was detected using the test kit from Kirkegaard &amp; Perry Laboratories following the manufacturer's protocol, and the absorbance was &lt;b&gt;read&lt;/b&gt; at 450 nm." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-27.anc" start="26002" end="26008" sStart="null" offset="53" sid="r9.normal.j.0277" wn="1" wnkey="normal%3:00:01::" text="Therefore, CAP would be expected to precipitate in a normal acidic vaginal environment." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-27.anc" start="2817" end="2823" sStart="null" offset="114" sid="r9.normal.j.0097" wn="3" wnkey="normal%3:00:03::" text="Since CAP, unlike the other polymers listed above, is not soluble at low pH, characteristic for a normal vaginal environment [ 42 ] , micronized forms of CAP had to be used in microbicidal formulations of this compound [ 30 31 32 33 34 ] . Therefore, it was of interest to determine how CAP in micronized form and other candidate polymeric microbicides affect X4 and R5 viruses represented by HIV-1 IIIB and BaL, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-27.anc" start="2817" end="2823" sStart="null" offset="114" sid="r9.normal.j.0097" wn="3" wnkey="normal%3:00:03::" text="Since CAP, unlike the other polymers listed above, is not soluble at low pH, characteristic for a normal vaginal environment [ 42 ] , micronized forms of CAP had to be used in microbicidal formulations of this compound [ 30 31 32 33 34 ] . Therefore, it was of interest to determine how CAP in micronized form and other candidate polymeric microbicides affect X4 and R5 viruses represented by HIV-1 IIIB and BaL, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-27.anc" start="2817" end="2823" sStart="null" offset="114" sid="r9.normal.j.0097" wn="1" wnkey="normal%3:00:01::" text="Since CAP, unlike the other polymers listed above, is not soluble at low pH, characteristic for a normal vaginal environment [ 42 ] , micronized forms of CAP had to be used in microbicidal formulations of this compound [ 30 31 32 33 34 ] . Therefore, it was of interest to determine how CAP in micronized form and other candidate polymeric microbicides affect X4 and R5 viruses represented by HIV-1 IIIB and BaL, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-27.anc" start="2817" end="2823" sStart="null" offset="114" sid="r9.normal.j.0097" wn="2" wnkey="normal%3:00:02::" text="Since CAP, unlike the other polymers listed above, is not soluble at low pH, characteristic for a normal vaginal environment [ 42 ] , micronized forms of CAP had to be used in microbicidal formulations of this compound [ 30 31 32 33 34 ] . Therefore, it was of interest to determine how CAP in micronized form and other candidate polymeric microbicides affect X4 and R5 viruses represented by HIV-1 IIIB and BaL, respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-27.anc" start="9145" end="9149" sStart="null" offset="33" sid="r9.fold.v.0507" wn="2147483645" wnkey="null" text="1) at serial 5-fold dilutions (2-fold to 3.9 ? 10 6-fold in 0.14 M NaCl-0." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2334-2-27.anc" start="18278" end="18282" sStart="null" offset="115" sid="r9.fold.v.0339" wn="2147483645" wnkey="null" text="All fractions were then precipitated by 3% PEG and the redissolved pellets tested at 2- to 256-fold dilutions for infectivity (see Methods section)." />
  </sentences>
</list>